LAMF Global Ventures I filed a preliminary [proxy poutling its proposed merger with Nuvo Group, which has developed an FDA-cleared remote pregnancy monitoring platform.
The transaction at deal announcement last August valued Nuvo at a pre-money equity valuation of $269 million and up to approximately $300 million in earnouts upon Nuvo achieving certain commercial milestones.
The SPAC’s board recently extended the deal deadline to April 16. The additional two months mark the fourth and fifth of up to six monthly extensions available. Read more.
